Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience

Rayner, LJA; Challapalli, A; Blackmore, E; Rea, K; Wells, N; White, P; Hilman, S; Masson, S; Huckett, R; Garadi, K; Garadi, K; Kirk, H; Kabala, J; Oikonomopoulou, V; Bahl, A

Abstract

Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience

Citation

Rayner, L., Challapalli, A., Blackmore, E., Rea, K., Wells, N., White, P., …Bahl, A. (2018). Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience. Journal of Clinical Oncology, 36(6), 328. https://doi.org/10.1200/JCO.2018.36.6_suppl.328

• Journal Article Type: Article
• Acceptance Date: Feb 9, 2018
• Online Publication Date: Feb 26, 2018
• Publication Date: Feb 26, 2018
• Deposit Date: Mar 9, 2018
• Publicly Available Date: Aug 28, 2018
• Journal: Journal of Clinical Oncology
• Print ISSN: 0732-183X
• Publisher: American Society of Clinical Oncology
• Peer Reviewed: Peer Reviewed
• Volume: 36
• Issue: 6
• Pages: 328
• DOI: https://doi.org/10.1200/JCO.2018.36.6_suppl.328
• Keywords: upfront, docetaxel, androgen deprivation therapy, elderly patient, metastatic hormone-naive prostate cancer, single institution experience
• Public URL: https://uwe-repository.worktribe.com/output/875646
• Publisher URL: http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.328
• Related Public URLs: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.6_suppl.328